The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib

Kuan-Chih ChenYen-Hsiang HuangKuo-Hsuan HsuJeng-Sen TsengGee-Chen ChangTsung-Ying Yang2026-02-032026-02-032023-0510.2147/OTT.S407301https://scholars.csmu.edu.tw/handle/123456789/4753[SDGs]SDG3The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinibjournal-article